Wednesday, October 23, 2013

“Pay-to-Play” Meetings Shed Light on FDA’s Role in Prescription Abuse Epidemic

Originally published by Alliance for Natural Health USA


October 22, 2013

Drug companies paid up to $25,000 to influence FDA policy—the latest in a decades-long FDA/Big Pharma scandal. 

What class of drugs:
 
We’ll give you a hint: they’re FDA-approved.

click here to continue reading on www.anh-usa.org...